TT-10
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TT-10, covering 2025-04-02 to 2025-04-02. Get the full timeline:
Most recent: Clinical Trial Update: TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors [Phase 1, Phase 2]